(Updates)
** Shares of medical equipment maker Revvity RVTY.N climb
~4.6% to $126.56, hitting highest since July
** RVTY raises FY forecast for adjusted profit per share to
$4.83-$4.87 from $4.70-$4.80
** Co reports Q3 adjusted profit of $1.28/share vs analysts'
average estimate of $1.13/share - data compiled by LSEG
** Favorable margins and lower tax rate enabled the profit
beat - TD Cowen analysts
** The company expects annual revenue between $2.75 bln and
$2.77 bln, down from its previous forecast of $2.77 bln to $2.79
bln
** Q3 revenue from RVTY's Life Sciences segment was $301
mln, missing expectations of $306.15 mln
** Stock up 15.1% YTD
(Reporting by Christy Santhosh)
((Christy.Santhosh@thomsonreuters.com))